J Appl Biomed 12:79-85, 2014 | DOI: 10.1016/j.jab.2013.05.001

Role of peroxisome proliferator-activated receptors δ (PPARδ) in rats showing endotoxemic heart failure

Ping-Chin Changa, Li-Jen Chenb, Juei-Tang Chengc,*
a Department of Infection, Chi-Mei Medical Center Liouying, Liou-Ying, Tainan City, Taiwan
b Graduate Institute of Basic Medical Science, College of Medicine, National Cheng Kung University, Tainan City, Taiwan
c Department of Medical Research, Chi-Mei Medical Center, Yong Kang City, Taiwan

PPARδ-dependent maintenance of inotropic function is mentioned as crucial for cardiomyocytes. However, change of PPARδ in endotoxins-induced cardiac dysfunction is still unclear. The present study is then designed to investigate the changes of PPARδ in rats showing LPS-induced cardiac dysfunction. In the in vivo experiments, adult Wistar rats were treated with intravenous injection of 10 mg/kg LPS for 6 h. The isolated heart determined in Langendorff apparatus and the hemodynamic analysis of rats used to measure the changes of cardiac function extra vivo and in vivo. We found that LPS decreased the cardiac contractility in isolated heart and lowered the hemodynamic dP/dtmax in rats. Also, this action of LPS was reversed by PPARδ agonist. In cultured neonatal rat cardiac cells incubated with LPS, the intracellular calcium concentration and troponin I phosphorylation were both reduced after the detection of intracellular calcium level and Western blotting analysis. PPARδ agonist also reversed both actions of LPS in cardiomyocyte. The obtained results suggest that LPS induced decreases in PPARδ expression and troponin I phosphorylation to result in acute heart failure similar to cardiac dysfunction in endotoxemia.

Keywords: LPS; PPARδ; GW0742; Heart failure; Endotoxemia

Received: May 3, 2013; Revised: May 31, 2013; Accepted: May 31, 2013; Published: April 1, 2014  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chang P, Chen L, Cheng J. Role of peroxisome proliferator-activated receptors δ (PPARδ) in rats showing endotoxemic heart failure. J Appl Biomed. 2014;12(2):79-85. doi: 10.1016/j.jab.2013.05.001.
Download citation

References

  1. Angus, D.C., Linde-Zwirble, W.T., Lidicker, J., Clermont, G., Carcillo, J., Pinsky, M.R., 2001. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 29, 1303-1310. Go to original source...
  2. Anker, S.D., Egerer, K.R., Volk, H.D., Kox, W.J., Poole-Wilson, P.A., Coats, A.J., 1997. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am. J. Cardiol. 79, 1426- 1430. Go to original source... Go to PubMed...
  3. Barish, G.D., Narkar, V.A., Evans, R.M., 2006. PPAR delta: a dagger in the heart of the metabolic syndrome. J. Clin. Invest. 116, 590-597. Go to original source... Go to PubMed...
  4. Bility, M.T., Devlin-Durante, M.K., Blazanin, N., Glick, A.B., Ward, J.M., Kang, B.H., Kennett, M.J., Gonzalez, F.J., Peters, J.M., 2008. Ligand activation of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) inhibits chemically induced skin tumorigenesis. Carcinogenesis 29, 2406-2414. Go to original source... Go to PubMed...
  5. Bone, R.C., Grodzin, C.J., Balk, R.A., 1997. Sepsis: a new hypothesis for pathogenesis of the disease process. Chest 112, 235-243. Go to original source... Go to PubMed...
  6. Bootman, M.D., Berridge, M.J., 1995. The elemental principles of calcium signaling. Cell 83, 675-678. Go to original source... Go to PubMed...
  7. Chen, Z.C., Yu, B.C., Chen, L.J., Cheng, J.T., 2013. Increase of peroxisome proliferator-activated receptor d (PPARd) by digoxin to improve lipid metabolism in the heart of diabetic rats. Horm. Metab. Res. 45, 364-371. Go to original source...
  8. Chen, Z.C., Yu, B.C., Chen, L.J., Cheng, K.C., Lin, H.J., Cheng, J.T., 2011. Characterization of the mechanisms of the increase in PPARdelta expression induced by digoxin in the heart using the H9c2 cell line. Br J Pharmacol. 163, 390-398. Go to original source... Go to PubMed...
  9. Cheng, L., Ding, G., Qin, Q., Huang, Y., Lewis, W., He, N., Evans, R. M., Schneider, M.D., Brako, F.A., Xiao, Y., Chen, Y.E., Yang, Q., 2004a. Cardiomyocyte-restricted peroxisome proliferatoractivated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat. Med. 10, 1245-1250. Go to original source... Go to PubMed...
  10. Cheng, L., Ding, G., Qin, Q., Xiao, Y., Woods, D., Chen, Y.E., Yang, Q., 2004b. Peroxisome proliferator-activated receptor delta activates fatty acid oxidation in cultured neonatal and adult cardiomyocytes. Biochem. Biophys. Res. Commun. 313, 277-286. Go to original source... Go to PubMed...
  11. Cheng, P.Y., Lee, Y.M., Wu, Y.S., Chang, T.W., Jin, J.S., Yen, M.H., 2007. Protective effect of baicalein against endotoxic shock in rats in vivo and in vitro. Biochem. Pharmacol. 73, 793-804. Go to original source... Go to PubMed...
  12. Chou, M.T., Lo, S.H., Cheng, K.C., Li, Y.X., Chen, L.J., Cheng, J.T., 2012. Activation of b-adrenoceptors by dobutamine may induce a higher expression of peroxisome proliferatoractivated receptors d (PPARd) in neonatal rat cardiomyocytes. Sci.World J. 248320. Go to original source... Go to PubMed...
  13. Felbinger, T.W., Suchner, U., Goetz, A.E., 1999. Treating patients with severe sepsis. N. Engl. J. Med. 341, 56-57. Go to original source... Go to PubMed...
  14. Friedman, G., Silva, E., Vincent, J.L., 1998. Has the mortality of septic shock changed with time. Crit. Care Med. 26, 2078-2086. Go to original source... Go to PubMed...
  15. Gaudel, C., Schwartz, C., Giordano, C., Abumrad, N.A., Grimaldi, P.A., 2008. Pharmacological activation of PPARbeta promotes rapid and calcineurin-dependent fiber remodeling and angiogenesis in mouse skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 295, E297-E304. Go to original source... Go to PubMed...
  16. Haider, N., Narula, N., Narula, J., 2002. Apoptosis in heart failure represents programmed cell survival, not death, of cardiomyocytes and likelihood of reverse remodeling. J. Card. Fail. 8, S512-S517. Go to original source... Go to PubMed...
  17. Hallaq, H.A., Haupert Jr., G.T., 1989. Positive inotropic effects of the endogenous Na+/K(+)-transporting ATPase inhibitor from the hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 86, 10080-10084. Go to original source... Go to PubMed...
  18. Harrington, L.S., Moreno, L., Reed, A., Wort, S.J., Desvergne, B., Garland, C., Zhao, L., Mitchell, J.A., 2010. The PPARbeta/delta agonist GW0742 relaxes pulmonary vessels and limits right heart hypertrophy in rats with hypoxia-induced pulmonary hypertension. PLoS One 5, e9526. Go to original source... Go to PubMed...
  19. Issemann, I., Green, S., 1990. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 645-650. Go to original source... Go to PubMed...
  20. Layland, J., Solaro, R.J., Shah, A.M., 2005. Regulation of cardiac contractile function by troponin I phosphorylation. Cardiovasc. Res. 66, 12-21. Go to original source... Go to PubMed...
  21. Li, L., Desantiago, J., Chu, G., Kranias, E.G., Bers, D.M., 2000. Phosphorylation of phospholamban and troponin I in betaadrenergic-induced acceleration of cardiac relaxation. Am. J. Physiol. Heart Circ. Physiol. 278, H769-H779. Go to original source... Go to PubMed...
  22. Liu, X., Takeda, N., Dhalla, N.S., 1996. Troponin I phosphorylation in heart homogenate from diabetic rat. Biochim. Biophys. Acta 1316, 78-84. Go to original source...
  23. Liu, Y.C., Chang, A.Y., Tsai, Y.C., Chan, J.Y., 2009. Differential protection against oxidative stress and nitric oxide overproduction in cardiovascular and pulmonary systems by propofol during endotoxemia. J. Biomed. Sci. 16, 8. Go to original source... Go to PubMed...
  24. Messer, A.E., Jacques, A.M., Marston, S.B., 2007. Troponin phosphorylation and regulatory function in human heart muscle: dephosphorylation of Ser23/24 on troponin I could account for the contractile defect in end-stage heart failure. J. Mol. Cell. Cardiol. 42, 247-259. Go to original source... Go to PubMed...
  25. Metzger, J.M., Westfall, M.V., 2004. Covalent and noncovalent modification of thin filament action: the essential role of troponin in cardiac muscle regulation. Circ. Res. 94, 146-158. Go to original source... Go to PubMed...
  26. Motawi, T.K., Darwish, H.A., Abd El Tawab, A.M., 2011. Effects of caffeic acid phenethyl ester on endotoxin-induced cardiac stress in rats: a possible mechanism of protection. J. Biochem. Mol. Toxicol. 25, 84-94. Go to original source... Go to PubMed...
  27. Niebauer, J., Volk, H.D., Kemp, M., Dominguez, M., Schumann, R. R., Rauchhaus, M., Poole-Wilson, P.A., Coats, A.J., Anker, S.D., 1999. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet 353, 1838-1842. Go to original source... Go to PubMed...
  28. Ohtsuki, I., Morimoto, S., 2008. Troponin: regulatory function and disorders. Biochem. Biophys. Res. Commun. 369, 62-73. Go to original source... Go to PubMed...
  29. Patten, M., Kramer, E., Bunemann, J., Wenck, C., Thoenes, M., Wieland, T., Long, C., 2001. Endotoxin and cytokines alter contractile protein expression in cardiac myocytes in vivo. Pflugers Arch. 442, 920-927. Go to original source... Go to PubMed...
  30. Pi, Y., Kemnitz, K.R., Zhang, D., Kranias, E.G., Walker, J.W., 2002. Phosphorylation of troponin I controls cardiac twitch dynamics: evidence from phosphorylation site mutants expressed on a troponin I-null background in mice. Circ. Res. 90, 649-656. Go to original source... Go to PubMed...
  31. Quintela, A.M., Jimenez, R., Gomez-Guzman, M., Zarzuelo, M.J., Galindo, P., Sanchez, M., Vargas, F., Cogolludo, A., Tamargo, J., Perez-Vizcaino, F., Duarte, J., 2012. Activation of peroxisome proliferator-activated receptor-beta/-delta (PPARbeta/delta) prevents endothelial dysfunction in type 1 diabetic rats. Free Radic. Biol. Med. 53, 730-741. Go to original source... Go to PubMed...
  32. Raeburn, C.D., Calkins, C.M., Zimmerman, M.A., Song, Y., Ao, L., Banerjee, A., Meng, X., Harken, A.H., 2001. Vascular cell adhesion molecule - 1 expression is obligatory for endotoxin-induced myocardial neutrophil accumulation and contractile dysfunction. Surgery 130, 319-325. Go to original source... Go to PubMed...
  33. Seldinger, S.I., 2008. Catheter replacement of the needle in percutaneous arteriography. A new technique. Acta Radiol. Suppl. (Stockholm) 434, 47-52. Go to original source... Go to PubMed...
  34. Sun, L., Li, D.L., Zhao, M., He, X., Yu, X.J., Miao, Y., Wang, H., Ren, J., Zang, W.J., 2011. The Role of Muscarinic Receptors in the Beneficial Effects of Adenosine against Myocardial Reperfusion Injury in Rats. PLoS One 6, e25618. Go to original source... Go to PubMed...
  35. Sznaidman, M.L., Haffner, C.D., Maloney, P.R., Fivush, A., Chao, E., Goreham, D., Sierra, M.L., LeGrumelec, C., Xu, H.E., Montana, V.G., Lambert, M.H., Willson, T.M., et al., 2003. Novel selective small molecule agonists for peroxisome proliferator-activated receptor delta (PPARdelta) - synthesis and biological activity. Bioorg. Med. Chem. Lett. 13, 1517- 1521. Go to original source... Go to PubMed...
  36. Tate, C.A., Hyek, M.F., Taffet, G.E., 1991. The role of calcium in the energetics of contracting skeletal muscle. Sports Med. 12, 208-217. Go to original source... Go to PubMed...
  37. Vanasco, V., Magnani, N.D., Cimolai, M.C., Valdez, L.B., Evelson, P., Boveris, A., Alvarez, S., 2012. Endotoxemia impairs heart mitochondrial function by decreasing electron transfer. ATP synthesis and ATP content without affecting membrane potential. J. Bioenerg. Biomembr. 44, 243-252. Go to original source... Go to PubMed...
  38. Wagner, N., Jehl-Pietri, C., Lopez, P., Murdaca, J., Giordano, C., Schwartz, C., Gounon, P., Hatem, S.N., Grimaldi, P., Wagner, K.D., 2009. Peroxisome proliferator-activated receptor beta stimulation induces rapid cardiac growth and angiogenesis via direct activation of calcineurin. Cardiovasc. Res. 83, 61-71. Go to original source... Go to PubMed...
  39. Werdan, K., Muller-Werdan, U., 1996. Elucidating molecular mechanisms of septic cardiomyopathy - the cardiomyocyte model. Mol. Cell. Biochem. 163-164, 291-303. Go to original source...
  40. Yang, Q., Li, Y., 2007. Roles of PPARs on regulating myocardial energy and lipid homeostasis. J. Mol. Med. 85, 697-706. Go to original source... Go to PubMed...